LGG
CVS icon

Luts & Greenleigh Group’s CVS Health CVS Stock Holding History

Luts & Greenleigh Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$441K Buy
+5,590
New +$398K 0.56% 35

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Luts & Greenleigh Group's CVS Position: Q4 2023 in Review

Luts & Greenleigh Group opened a new position in CVS Health (CVS) in Q4 2023: 5,590 shares worth $441K. The stake represents 0.56% of the portfolio and ranks #35 among its holdings.

2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Luts & Greenleigh Group held 5,590 shares of CVS Health worth $441K as of Q4 2023.
  • CVS Health was a new Luts & Greenleigh Group position in Q4 2023.
  • CVS Health made up 0.56% of Luts & Greenleigh Group's portfolio in Q4 2023, its #35 holding.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Luts & Greenleigh Group's 13F filing for Q4 2023, filed 29 Jan 2024.